DAFNA Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$1.89M Hold
2017
Q3
$1.72M Hold
2017
Q2
$1.35M Sell
2017
Q1
$2.61M Hold
2016
Q4
$1.52M Hold
2016
Q3
$2.25M Hold
2016
Q2
$1.7M Buy